CN105251010A - Medicinal composition for treating atherosclerosis and preparation method of medicinal composition - Google Patents

Abstract

The invention discloses a medicinal composition for treating atherosclerosis and a preparation method of the medicinal composition. The medicinal composition is prepared from the following raw materials in parts by weight: 1 to 2 parts of fibrate medicines, 0.1 to 0.9 part of probucol and 50 to 200 parts of traditional Chinese medicinal composition, wherein the traditional Chinese medicinal composition comprises salvia miltiorrhiza, zedoary, kudzuvine root, sophora japonica, dried orange peel, hedyotis diffusa, hovenia dulcis thumb, herba epimedii, rhizome of large-headed atractylodes, cnidium monnieri, milkwort, gynostemma pentaphyllum, polygonum cuspidatum and cattail pollen. According to the medicinal composition disclosed by the invention, the fibrate medicines and the probucol are combined for treating the atherosclerosis and both have remarkable synergistic effect, but have greater toxic or side effects; based on reasons, traditional Chinese medicinal raw materials are added for radical treatment and assisting two kinds of western medicines; according to the traditional Chinese medicinal composition provided by the invention, from root causes of disease, the atherosclerosis is thoroughly and effectively treated.

Description

One treats atherosclerotic pharmaceutical composition and preparation method thereof

Technical field

The invention belongs to medical art, be specifically related to one and treat atherosclerotic pharmaceutical composition and preparation method thereof.

Background technology

Atherosclerosis is common cardiovascular disease, and along with the change of China's living standard raising and dietary habit, atherosclerotic sickness rate also raises gradually, and this disease also becomes one of underlying cause of death of the cardiovascular patient of China.At atherosclerotic late stage, due to the effect of metallo-matrix proteases, expose vulnerable plaque, activate thrombin and platelet, cause platelet aggregation, thrombosis, so that the position ischemic infarction that the generation of acute coronary syndrome, apoplexy and this blood vessel are arranged, have a strong impact on the physical and mental health of the mankind.

The atherosclerotic method of Current therapeutic comprises operative treatment, western medicine and treatment by Chinese herbs.But atherosclerosis is apt to occur in old people, operation wound is large, is unfavorable for the recovery of patient, and operation costly.The atherosclerotic Western medicine of current treatment mainly comprises following a few class: 1, Statins is to reduce the fat regulation medicine of triglyceride and low density lipoprotein, LDL; 2, the antiplatelet medicine that sticks and assemble; 3, thrombus dissolving and anticoagulant; 4 for the symptomatic treatment medicine of ischemia symptom as the vasodilation applied and beta-blocker etc. during treatment angina pectoris.But these Western medicine often cause untoward reaction, are especially not suitable for long-term prescription.

Fibrate is also known as fibrate drug, this type of medicine is by peroxide activator enzyme accretion prism activated receptor α (PPAR α), stimulate the expression of lipoprotein lipase (LPL), apoAI and apoAII gene, and suppress the expression of apoCIII gene, strengthen the lipolytic activity of LPL, be conducive to removing triglyceride-rich lipoprotein in blood circulation, reduce plasma TG and improve HDL-C level, promote the antiport of cholesterol, and make LDL hypotype by small and dense granule to large and loose particles changes.The special class indication of shellfish is hypertriglyceridemia or based on the combined hyperlipidemia familial of TG rising and low hdl mass formed by blood stasis.The modal untoward reaction of the special class of shellfish is gastrointestinal upset, mostly is slight and feels sick, diarrhoea and abdominal distention etc., and usual short duration, does not need drug withdrawal.In addition, accidental skin pruritus, urticaria, erythra, alopecia, headache, insomnia and hyposexuality etc.These reactions are general also very light, are more common within the several weeks at the beginning of taking medicine, do not need drug withdrawal also can die away.The obvious person of indivedual symptom should reduce dosage or drug withdrawal.During long-term taking shellfish spy class, just should watch out for drug-induced Liver and kidney function and compromise.So, originally just there is the patient of liver and kidney defect should be cautious use of these medicines.Drug rhabdomyolysis may be there is after also having few patients to take medicine, show as myalgia, unable, sometimes also have muscle twitches.At this moment measure creatase content in blood, often obviously raise.Therefore, period in a medicine patient regularly should look into the creatase content in Liver and kidney function and serum.So that doctor adjusts drug dose in time according to result of laboratory test, avoid untoward reaction.In addition, the special class of shellfish can make the incidence rate of cholelithiasis raise, and the amount that cholesterol may be made to enter bile with this type of medicine increases, and promotes that cholelithiasis is formed relevant, therefore the patient of the existing biliary tract such as cholelithiasis or cholecystitis should careful medication.The special class of shellfish has certain toxicity to embryo, and embryo growth can be made to postpone, so anemia of pregnant woman, women breast-feeding their children preferably do not take, Women of Childbearing Age and child generally also should not use this type of medicine.After individuals patients takes medicine, leukocyte, erythrocyte and eosinophilic granulocyte may reduce, and make regular check on routine blood test and contribute to these abnormal changes of early discovery.

Probucol has the effect of adjusting blood lipid.As fat-reducing medicament, the modal untoward reaction of this product is gastrointestinal upset, and the incidence rate of diarrhoea is approximately 10%, also has flatulence, stomachache, nausea and vomiting.Other rare reactions have: headache, dizziness, paraesthesia, insomnia, tinnitus, erythra, skin pruritus etc.Serious untoward reaction has: electrocardiogram Q-T interval prolongation, ventricular tachycardia, thrombocytopenia etc.

In order to improve blood fat compliance rate, reduce the incidence rate of untoward reaction, the use in conjunction of different classes of fat regulation medicine or other classification medicine class is a rational approach simultaneously.But during drug combination, when especially dosage is larger, the generation of abnormal liver function and myolysis disease obviously increases, and untoward reaction is more remarkable.Although western medicine disease quick result, toxic and side effects is comparatively large, zest and dependency strong, atherosclerosis can not get eradicating.

The atherosclerotic curative effect of Chinese traditional treatment prove by a large amount of clinical trials, Chinese medicine at adjusting blood lipid, regulate in immunity of organism etc. and can play good curative effect, but the problem such as Chinese medicine preparation ubiquity onset is at present slower.

At present, fibrate and probucol use in conjunction be not on treatment atheromatosis, and, adopt Chinese medicine class adjuvant to produce synergistic therapeutic effect as carrier.

Summary of the invention

One is the object of the present invention is to provide to treat atherosclerotic pharmaceutical composition and preparation method thereof.

The present invention is by the following technical solutions:

One treats atherosclerotic pharmaceutical composition, is to be made up of the raw material of following weight portion: fibrate 1 ~ 2 part, probucol 0.1 ~ 0.9 part, Chinese medicine composition 50 ~ 200 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 8 ~ 20 parts, Rhizoma Curcumae 5 ~ 15 parts, Radix Puerariae 5 ~ 15 parts, 10 ~ 20 parts, Flos Sophorae, Pericarpium Citri Reticulatae 5 ~ 10 parts, Herba Hedyotidis Diffusae 15 ~ 20 parts, Semen Hoveniae (Fructus Hoveniae) 12 ~ 18 parts, Herba Epimedii 5 ~ 12 parts, the Rhizoma Atractylodis Macrocephalae 20 ~ 25 parts, Fructus Cnidii 5 ~ 10 parts, Radix Polygalae 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 5 ~ 8 parts, Rhizoma Polygoni Cuspidati 16 ~ 30 parts, Pollen Typhae 8 ~ 15 parts.

Preferably, the high atherosclerotic pharmaceutical composition of described treatment is made up of the raw material of following weight portion: fibrate 1 ~ 1.2 part, probucol 0.1 ~ 0.3 part, Chinese medicine composition 100 ~ 180 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 13 ~ 18 parts, Rhizoma Curcumae 8 ~ 12 parts, Radix Puerariae 12 ~ 15 parts, 10 ~ 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 ~ 10 parts, Herba Hedyotidis Diffusae 15 ~ 18 parts, Semen Hoveniae (Fructus Hoveniae) 14 ~ 18 parts, Herba Epimedii 8 ~ 12 parts, the Rhizoma Atractylodis Macrocephalae 22 ~ 25 parts, Fructus Cnidii 6 ~ 10 parts, Radix Polygalae 12 ~ 15 parts, Herb Gynostemmae Pentaphylli 6 ~ 8 parts, Rhizoma Polygoni Cuspidati 20 ~ 30 parts, Pollen Typhae 12 ~ 15 parts.

Can obtain through a large amount of experiments and analysis, its drug effect of compositions and the curative effect of the raw material composition of preferred above-mentioned weight portion are better.

Preferred further, the atherosclerotic pharmaceutical composition of described treatment is made up of the raw material of following weight portion: fibrate 1.2 parts, probucol 0.2 part, Chinese medicine composition 100 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Curcumae 10 parts, Radix Puerariae 12 parts, 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 parts, Herba Hedyotidis Diffusae 18 parts, Semen Hoveniae (Fructus Hoveniae) 15 parts, Herba Epimedii 10 parts, the Rhizoma Atractylodis Macrocephalae 22 parts, Fructus Cnidii 9 parts, Radix Polygalae 14 parts, Herb Gynostemmae Pentaphylli 8 parts, Rhizoma Polygoni Cuspidati 25 parts, Pollen Typhae 12 parts.

Can obtain through a large amount of experiments and analysis, its drug effect of compositions and the curative effect of the raw material composition of preferred above-mentioned weight portion are best.

Described fibrate refers to fibrate lipid lowerers, as CLOF, bezafibrate, FENOBRATE top grade or its pharmaceutically acceptable salt or ester or derivatives thereof.Preferably CLOF.Through a large amount of experiments with analyze can obtain, its drug effect of compositions coordinating other raw material to form by CLOF and curative effect better.

The preparation method of the atherosclerotic pharmaceutical composition of described treatment, comprises the following steps:

(1) Chinese medicine ingredients is extracted: by the raw material of Chinese medicine except Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, add water until raw material of Chinese medicine described in submergence, decocts 1 ~ 2h, obtains decocting liquid, described decocting liquid is filtered, is removed slag, obtains filtrate; Concentrated described filtrate, obtains thick paste;

(2) sterilizing: described thick paste and described Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae are carried out sterilizing, 105-110 DEG C of sterilizing 20 ~ 30 minutes;

(3) dry: by the thick paste after sterilizing, Radix Puerariae, Radix Salviae Miltiorrhizae, Rhizoma Polygoni Cuspidati and Pollen Typhae, at 60-80 DEG C of dry 6-7 hour;

(4) pulverize: dried raw material is added fibrate and probucol, is ground into 80-100 order fine powder, obtain medical treatment atherosclerotic pharmaceutical composition.

Above-mentioned composition is made clinical acceptable dosage form, as tablet, capsule, powder, granule and oral liquid etc.

Described pharmaceutical composition coordinates other treatment atherosclerosis drug use.

Using method: 2 times on the one, takes 0.5-1g 1 time, within 7 days, is a course for the treatment of, can fully recover after using 1-3 the course for the treatment of continuously.

The pharmacological property of described raw material of Chinese medicine:

Radix Salviae Miltiorrhizae: bitter in the mouth, is slightly cold.GUIXIN, Liver Channel.There is promoting blood circulation to remove blood stasis, detumescence hemostasis, anti-inflammatory analgetic, menstruction regulating and pain relieving, coronary artery dilator, improve myocardial ischemia situation, reduce blood pressure, calm the nerves with all worries set aside, blood sugar lowering and the effect such as antibacterial, menoxenia, amenorrhea dysmenorrhea, hematogenous blockage, traumatic injury, skin infection are swollen and ache, vexed insomnia, the disease such as angina pectoris have certain curative effect.

Rhizoma Curcumae, pungent, bitter, temperature.Return liver, spleen channel.Effect: (1) removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.For abdominal pain due to blood stasis, hepatosplenomegaly, trusted subordinate's distending pain, gather, women's blood stasis amenorrhea, traumatic injury is had a pain eating accumulation.(2) promoting the circulation of QI to relieve pain, removing blood stasis removing food stagnancy: for the amenorrhea of qi depression to blood stasis, chest and hypochondrium, stomachache and lump in the abdomen lump etc.(3) promoting digestion and removing stagnation: for the stomach abdominal distention and pain of eating accumulation.

Radix Puerariae, sweet in the mouth, pungent, cool in nature.Attach to the lung and stomach meridians.Effect: expelling pathogenic factors from muscles for reducing heat, rash, promoting the production of body fluid to quench thirst, yang invigorating antidiarrheal.Cure mainly: for exterior syndrome heating, stiff nape and back, measles without adequate eruption, calentura is thirsty, and the deficiency of YIN is quenched one's thirst, diarrhea of heat type hematodiarrhoea, diarrhea due to hypofunction of the spleen.

Flos Sophorae, bitter in the mouth, cold nature, return liver, large intestine channel; Enter blood to hold back and fall, body slightly falls apart; There is cooling blood for hemostasis, effect of purging liver-fire; Cure mainly discharging fresh blood stool, hemorrhoidal bleeding, dysentery, hematuria, stranguria with blood, metrorrhagia, spit blood, epistaxis, liver-fire is had a headache, conjunctival congestion and swelling pain, sore throat, aphonia, ulcer sores.From the angle of doctor trained in Western medicine, Flos Sophorae is containing materials such as rutin (i.e. rutin, Rytub), Quercetin (Quercetin), tannin, sophoradiol (sophoradiol), vitamin A.Rutin can improve the function of blood capillary, and keep the normal resistance of blood capillary, prevent because capillary fragility is excessive, too high hemorrhage, hypertension, the diabetes caused of permeability, can preventing of clothes is hemorrhage.

Pericarpium Citri Reticulatae, bitter in the mouth, pungent, warm in nature.Return lung, spleen channel.For distension and fullness in the abdomen, lack of appetite and vomiting, cough with copious phlegm.

Herba Hedyotidis Diffusae, mildly bitter flavor, sweet, cold in nature; Return stomach, large intestine, small intestine meridian.Function: heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain.

Semen Hoveniae (Fructus Hoveniae), sweet, flat, enter the heart, spleen two warp.Function: clearing away heat and promoting diuresis, cough-relieving relieving restlessness, alcoholic intoxication.

Herba Epimedii, abnormal smells from the patient is pungent, warm, nontoxic.Enter liver, kidney channel.Kidney invigorating and YANG supporting, expelling wind and removing dampness.For sexual impotence, frequent micturition, weakness of the waist and knees and the disease such as anemofrigid-damp arthralgia or numb limbs and tense tendons.

The Rhizoma Atractylodis Macrocephalae, bitter in the mouth, sweet, warm in nature.Return spleen, stomach warp.Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, frequent fetal movement.

Fructus Cnidii, warm in nature, bitter in the mouth, returns kidney channel.Function cures mainly: warming the kidney to invigorate YANG, and dampness is dispeled the wind, parasite killing.For sexual impotence, cold womb, cold-damp leukorrhagia, arthralgia chiefly caused by damp pathogen lumbago; External treatment vulval eczema, married woman's pudendal pruritus, trichomonal vaginitis.

Radix Polygalae, bitter, pungent, warm.GUIXIN, kidney, lung meridian.To calm the nerves Fructus Alpiniae Oxyphyllae, resolving depression.Control palpitation with fear, forgetful, nocturnal emission, insomnia, cough ant phlegm, carbuncle skin ulcer swells.

Herb Gynostemmae Pentaphylli, bitter in the mouth; Micro-sweet; Cool in nature.Return lung; Spleen; Kidney channel.Effect: replenishing QI to invigorate the spleen, preventing phlegm from forming and stopping coughing, heat-clearing and toxic substances removing.Cure mainly: body void is weak; Nephrasthenia emission; Leukopenia; Hyperlipemia; Viral hepatitis; Chronic gastroenteritis; Chronic tracheitis.

Rhizoma Polygoni Cuspidati, mildly bitter flavor, cold nature.Return liver, gallbladder, lung meridian.Effect: dampness removing jaundice eliminating, heat-clearing and toxic substances removing, eliminating stasis to stop pain, relieving cough and resolving phlegm.Emodin composition contained by Rhizoma Polygoni Cuspidati, can reduce exogenous hypercholesterolia and enter in body, and zoopery shows that Rhizoma Polygoni Cuspidati has obvious effect for reducing fat.

Pollen Typhae, sweet, flat.Return liver, pericardium channel.Hemostasis, blood stasis dispelling, treating stranguria.For spitting blood, epistaxis, spitting of blood, metrorrhagia, traumatic hemorrhage, amenorrhea stimulates the menstrual flow, breast ventral spine pain, tumbling and swelling, blood strangury and dry pain.Obviously can reduce the absorption of cholesterol at intestinal, promote that it discharges in feces, and have the effect of atherosclerosis and reduction serum sterin.

The invention has the beneficial effects as follows:

The present invention adopts fibrate and probucol to combine treatment atherosclerosis, and both have obvious synergistic function, but toxic and side effects is comparatively large, adds raw material of Chinese medicine be used for radical cure and auxiliary two kinds of Western medicine for this present invention.Chinese medicine composition provided by the present invention, starts with from morbidity root, fundamentally effectively treats atherosclerosis; The present invention adopts the Chinese crude drug of different properties, scientific compatibility, Pollen Typhae, Rhizoma Polygoni Cuspidati, Herb Gynostemmae Pentaphylli, Radix Salviae Miltiorrhizae and Flos Sophorae energy dampness removing jaundice eliminating, heat-clearing and toxic substances removing, and eliminating stasis to stop pain, coordinates with two kinds of Western medicine, treating both the principal and secondary aspects of a disease, changes blood blood stasis dispelling, removing dampness dredging collateral, has obvious effect for reducing fat; Rhizoma Curcumae and the circulation of qi promoting of Pericarpium Citri Reticulatae removing blood stasis, removing food stagnancy pain relieving, can alleviate the symptom such as diarrhoea, flatulence that Western medicine produces; The kidney and spleen invigoratings such as Radix Polygalae, Herba Epimedii, Herba Hedyotidis Diffusae, the Rhizoma Atractylodis Macrocephalae and Radix Puerariae protect the liver, and what alleviation Western medicine produced suffers from a deficiency of the kidney, damage the side effect such as liver.Pharmaceutical composition of the present invention safely, effective, treatment cost is low, and therapeutic effect is remarkable.

Chinese medicine and western medicine of the present invention combines, alleviate the side effect that Western medicine causes human body in treatment atherosclerosis, the T-CHOL in atherosclerosis serum, triglyceride and low density lipoprotein, LDL can be reduced, alleviate the formation of atheromatous plaque, to reducing T-CHOL, the level of low density lipoprotein, LDL and the formation that alleviates atheromatous plaque, there is significant curative effect, take blood lipid-lowering medicine curative effect than folk prescription more remarkable, its preparation method be simple, safety.

Detailed description of the invention

Embodiment 1

One treats atherosclerotic pharmaceutical composition, is to be made up of the raw material of following weight portion: CLOF 1.2 parts, probucol 0.2 part, Chinese medicine composition 100 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Curcumae 10 parts, Radix Puerariae 12 parts, 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 parts, Herba Hedyotidis Diffusae 18 parts, Semen Hoveniae (Fructus Hoveniae) 15 parts, Herba Epimedii 10 parts, the Rhizoma Atractylodis Macrocephalae 22 parts, Fructus Cnidii 9 parts, Radix Polygalae 14 parts, Herb Gynostemmae Pentaphylli 8 parts, Rhizoma Polygoni Cuspidati 25 parts, Pollen Typhae 12 parts.

The preparation method of the atherosclerotic pharmaceutical composition of described treatment, comprises the following steps:

(1) Chinese medicine ingredients is extracted: by the raw material of Chinese medicine except Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, add water until raw material of Chinese medicine described in submergence, decocts 1.5h, obtains decocting liquid, described decocting liquid is filtered, is removed slag, obtains filtrate; Concentrated described filtrate, obtains thick paste;

(2) sterilizing: described thick paste and described Radix Puerariae, Rhizoma Polygoni Cuspidati and Pollen Typhae are carried out sterilizing, 110 DEG C of sterilizings 30 minutes;

(3) dry: by the thick paste after sterilizing, Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, 70 DEG C of dryings 6.5 hours;

(4) pulverize: dried raw material is added CLOF and probucol, is ground into 100 order fine powders, makes tablet, obtain medical treatment atherosclerotic pharmaceutical composition.

Embodiment 2

One treats atherosclerotic pharmaceutical composition, is to be made up of the raw material of following weight portion: bezafibrate 1 part, probucol 0.1 part, Chinese medicine composition 150 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 13 parts, Rhizoma Curcumae 8 parts, Radix Puerariae 12 parts, 10 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 parts, Herba Hedyotidis Diffusae 15 parts, Semen Hoveniae (Fructus Hoveniae) 14 parts, Herba Epimedii 8 parts, the Rhizoma Atractylodis Macrocephalae 22 parts, Fructus Cnidii 6 parts, Radix Polygalae 12 parts, Herb Gynostemmae Pentaphylli 6 parts, Rhizoma Polygoni Cuspidati 20 parts, Pollen Typhae 12 parts.

The preparation method of the atherosclerotic pharmaceutical composition of described treatment, comprises the following steps:

(1) Chinese medicine ingredients is extracted: by the raw material of Chinese medicine except Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, add water until raw material of Chinese medicine described in submergence, decocts 1h, obtains decocting liquid, described decocting liquid is filtered, is removed slag, obtains filtrate; Concentrated described filtrate, obtains thick paste;

(2) sterilizing: described thick paste and described Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae are carried out sterilizing, 105 DEG C of sterilizings 20 minutes;

(3) dry: by the thick paste after sterilizing, Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, 60 DEG C of dryings 7 hours;

(4) pulverize: dried raw material is added bezafibrate and probucol, is ground into 80 order fine powders, makes granule, obtain medical treatment atherosclerotic pharmaceutical composition.

Embodiment 3

One treats atherosclerotic pharmaceutical composition, is to be made up of the raw material of following weight portion: fenofibrate 2 parts, probucol 0.3 part, Chinese medicine composition 180 parts; Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 18 parts, Rhizoma Curcumae 12 parts, Radix Puerariae 15 parts, 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 10 parts, Herba Hedyotidis Diffusae 18 parts, Semen Hoveniae (Fructus Hoveniae) 18 parts, Herba Epimedii 12 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Fructus Cnidii 10 parts, Radix Polygalae 15 parts, Herb Gynostemmae Pentaphylli 8 parts, Rhizoma Polygoni Cuspidati 30 parts, Pollen Typhae 15 parts.

The preparation method of the atherosclerotic pharmaceutical composition of described treatment, comprises the following steps:

(1) Chinese medicine ingredients is extracted: by the raw material of Chinese medicine except Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, add water until raw material of Chinese medicine described in submergence, decocts 2h, obtains decocting liquid, described decocting liquid is filtered, is removed slag, obtains filtrate; Concentrated described filtrate, obtains thick paste;

(2) sterilizing: described thick paste and described Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae are carried out sterilizing, 110 DEG C of sterilizings 20 minutes;

(3) dry: by the thick paste after sterilizing, Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, 80 DEG C of dryings 6 hours;

(4) pulverize: dried raw material is added fenofibrate and probucol, is ground into 90 order fine powders, makes tablet, obtain medical treatment atherosclerotic pharmaceutical composition.

Comparative example 1

One treats atherosclerotic pharmaceutical composition, is to be made up of the raw material of following weight portion: CLOF 1.2 parts, probucol 0.2 part, soluble starch 150 parts, is made into tablet and obtains medical treatment atherosclerotic pharmaceutical composition.

Animal experiment: blood fat raise be one of atherosclerotic diagnosis index, therefore after medication blood fat change reflection medicine to atherosclerotic therapeutic effect.

Pharmacodynamics test is as follows:

Prepare hyperlipemia Carnis Coturnicis japonicae model, blank group oral normal saline, the compositions of positive controls oral contrast example 1, in the embodiment of the present invention 1, treat the oral tablet being divided into three dosage groups of atherosclerosis medicine group.Observe the present invention and treat atherosclerosis medicine to the impact of serum total cholesterol, triglyceride, low density lipoprotein, LDL and high density lipoprotein index and the impact on atheromatous plaque in hyperlipemia Carnis Coturnicis japonicae model serum.

Impact on Carnis Coturnicis japonicae experimental hyperlipidemia model serum lipids:

Get male and healthy Carnis Coturnicis japonicae, with normal diet (containing mass fraction be 49% Semen Maydis, 17% soybean cake powder, 24% fishbone powder, 8.90% Testa Tritici, 1% cod-liver oil, 0.1% Sal) feed 1 week.Then get Carnis Coturnicis japonicae 90, be divided into 6 groups at random, often organize 15, be respectively saline control group, model group, positive controls medicine comparative example 1 group and three various dose the present invention and treat atherosclerosis medicine group.Saline control group every every day with normal diet 20 grams nursing, and with normal saline once a day, each 1ml gavage, continuous 8 weeks.Model group every is fed with modeling feedstuff (1.5% cholesterol, 4% Oleum Arachidis hypogaeae semen, 17% Adeps Sus domestica mix with 77.5% normal diet) 20g every day, and with normal saline once a day, each 1ml gavage, continuous 8 weeks.Positive control drug comparative example 1 group uses modeling forage feed, and by comparative example 1 by per kilogram of body weight 0.14g gavage, once a day, continuous 8 weeks.Atherosclerosis medicine of the present invention high, medium and low dosage group modeling forage feed, and respectively with the present invention treat atherosclerosis medicine by per kilogram of body weight 1.2,0.6,0.3g gavage, once a day, continuous 8 weeks.Illumination every day keeps being greater than 12 hours.After last administration, fasting can't help water 12 hours, taking blood from jugular vein prepares serum, measures T-CHOL (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), HDL-C (HDL-C) according to test kit description method.Get aorta to reject adventitial fat and knit, longitudinally cut at dorsal surface, lie in square plate, the formalin with 10% fixes 24 hours, then dyes 30 minutes with soudan III, and after dyeing, milky white speckle is coloured to golden red.And do histopathologic examination.The grade scale of Aortic Plaque: 0 grade: intimal surface is smooth, without golden red change, namely without speckle; 1 grade: inner membrance has golden red change widely, but without the speckle of protuberate; 2 grades: the speckle having the golden red protuberate of affirmative, wherein maximum area is no more than 3 square millimeters; 3 grades: have the golden red of affirmative to protrude from the speckle on surface, wherein bulk area is more than 3 square millimeters; 4 grades: have many specklees differed in size, some fusions are in blocks, or the speckle that inner membrance is almost fusion covered.

The present invention treats the impact (n=15) of atherosclerosis medicine on experimental hyperlipidemia Serum of Quail blood fat

Group	TG(mmol/L)	TC(mmol/L)	HDL-C(mmol/L)	LDC-C(mmol/L)
					Blank group	1.30±0.33	6.15±1.13	1.56±0.44	3.62±0.91
Model group	3.36±2.16	29.09±8.15	4.61±0.19	6.89±0.79
					Positive controls	2.64±1.33	23.46±8.84	4.04±0.60	6.35±2.14
Low dose group of the present invention	1.88±2.33	15.66±8.35	3.68±0.75	5.88±0.55
					High dose group of the present invention	1.77±2.66	21.44±8.08	4.09±0.39	6.08±0.73

High dose group of the present invention

2.02±2.59

22.24±8.51

4.01±0.42

6.68±0.59

The present invention treats the impact (n=15) of atherosclerosis medicine on experimental hyperlipidemia Atherosclerotic quail speckle

Group	Dosage	Number of animals	Plaque index
				Blank group	1mL normal saline	15	0.20±0.47
Model group	1mL normal saline	15	2.24±0.87
				Positive controls	0.3g/kg	15	1.29±0.61
Dosage group in the present invention	0.3g/kg	15	0.79±0.74
				Low dose group of the present invention	0.6g/kg	15	1.09±0.45
High dose group of the present invention	1.2g/kg	15	1.15±0.21

Experimental result shows: the present invention treats the level that atherosclerosis medicine low dose group (0.3g/Kg dosage) and high dose group (1.2g/Kg dosage) obviously can reduce T-CHOL, triglyceride and low-density lipoprotein cholesterol in experimental hyperlipidemia Serum of Quail, alleviates the formation of atheromatous plaque.The compositions that the present invention treats in atherosclerosis medicine and positive control medicine comparative example 1 compares, in low dose group, the former can reduce the level of serum total cholesterol and low-density lipoprotein cholesterol better compared with the latter, alleviate the formation of atheromatous plaque, contrast has significant difference (P < 0.01), and do not lower the level of serum High Density Lipoprotein Cholesterol simultaneously, contrast with model group and there is no significant difference (P > 0.05).

Pharmacodynamics result shows: the present invention treats atherosclerosis medicine can reduce T-CHOL, triglyceride and low-density lipoprotein cholesterol in hyperlipemia Carnis Coturnicis japonicae model serum, alleviate the formation of atheromatous plaque, reduce T-CHOL, low-density lipoprotein cholesterol level and alleviate atheromatous plaque formation in be better than the compositions of comparative example 1.

Pharmacology pharmacodynamic is tested:

1, cumulative toxicity test report

Test method: the tablet of the embodiment of the present invention 1 is pressed 0.5,1.0 and 3g compositions/kg continuous use 12 weeks (1.0ml/100g body weight to rat, every day 2 times) and drug withdrawal after 4 weeks, result shows: the index such as hair, behavior, defecation, body weight, organ weights, hemogram, hepatic and renal function, blood glucose, blood fat of the present composition to rat all has no significant effect, internal organs naked eyes do not find that difference change and histological indications show, medication 12 weeks and drug withdrawal are after 4 weeks, and each internal organs of rat are all without obviously changing.Illustrate that compositions of the present invention is little to toxicity after rat long-term prescription, also there is no difference reaction after drug withdrawal, application safety.

2, acute toxicity test: application NIH mice 40, SPF level, male and female half and half, body weight 16 ~ 20g, carries out acute toxicity test.Mice is divided into two groups at random, often organizes 20, i.e. matched group and administration group, fasting 12 hours before experiment; In water, (concentration is 0.12g crude drug/ml to the tablet prepared by embodiments of the invention 1, maximum concentration) gavage, gavage volume is 5ml/kg (namely unit dosage form is 0.6g crude drug/kg), matched group gives normal saline, administration in one day 2 times, delivery time 6 hours, Continuous Observation 14 days after administration, and record toxic reaction and the death toll of mice.Experimental result shows: compare with matched group, and after administration, mice has no notable difference, and experiment Continuous Observation 14 days, mouse systemic situation, diet, drinking-water, body weight increase all normal.Mouse oral gavage tablet LD50>0.6g crude drug/kg of the present invention, every day, maximum dosage-feeding was 0.65 crude drug/kg/ day.Therefore compositions acute toxicity of the present invention is low, clinical drug safety.

Clinical data:

1, data and method

1.1 physical data: during selecting in April, 2012 in December ,-2013, the atherosclerotic patient of certain hospitalize is totally 400 examples, wherein, man 200 example, female 200 example, age 30-70 year.Be divided into two groups at random, treatment group 300 example, matched group 100 example.Two groups of patients comparing difference not statistically significant in age, sex, state of an illness weight, has comparability, and according to the weight out-patient treatment of the state of an illness.

1.2 criterions of therapeutical effect: its criterion of therapeutical effect: be divided into healing, effective, effective, invalid.

Cure: standard CT A imaging or coronary angiography, soft speckle disappears, arteria coronaria blood vessel without narrow or only there is the speckle of calcification, luminal stenosis < 10%, without clinical symptoms, normal ECG;

Effective: CTA imaging or coronarography, soft speckle reduces 50-70%.Coronary stenosis comparatively front minimizing 50-70% clinical symptoms obviously alleviates or without clinical symptoms, electrocardiogram is slight, and ST-T changes;

Effective: CTA imaging or coronarography, soft speckle reduces 20-38%.Clinical symptom relief, angina pectoris attacks number of times, pain degree, duration of seizure reduce.Electrocardiogram: ST-T changes existence, but ST moves down, T ripple is inverted degree and is alleviated;

Invalid: CTA imaging and coronarography, soft speckle reduces < 10%, and clinical symptoms is without change, and electrocardiogram is without change.

1.3 Therapeutic Method and therapeutic effect

1.3.1 treatment group is three treatment group 1-3 at random, uses the compositions of the different preparations of embodiment of the present invention 1-3 to treat respectively:

(1) treatment group 1:100 example patient uses the tablet of embodiment 1, twice on the one, once take 0.5-1g, within 7 days, be a course for the treatment of, after using 1-3 the course for the treatment of continuously, drug withdrawal further consultation again in a week, statistics finds healing 78 patients, 17 patient treatments are effective, and 5 patient treatments are effective, and 0 patient is invalid.Treatments period, does not find the side effect that medicine brings, follows up a case by regular visits to half a year, cures patient all without any the symptom of recurrence for 78.

(2) treatment group 2:100 example patient uses the granule of embodiment 2, twice on the one, once take 0.5-1g, within 7 days, be a course for the treatment of, after using 1-3 the course for the treatment of continuously, drug withdrawal further consultation again in a week, statistics finds healing 79 patients, 16 patient treatments are effective, and 4 patient treatments are effective, and 1 patient is invalid.Treatments period, does not find the side effect that medicine brings, follows up a case by regular visits to half a year, cures patient all without any the symptom of recurrence for 79.

(3) treatment group 3:100 example patient uses the tablet of embodiment 3,2 times on the one, take 0.5-1g 1 time, within 7 days, be a course for the treatment of, after using 1-3 the course for the treatment of continuously, drug withdrawal further consultation again in a week, statistics finds the routine patient of healing 80,15 routine patient treatments are effective, and 4 routine patient treatments are effective, and 1 routine patient treatment is invalid.Do not find other side effect that medicine brings during 100 routine patient treatments, follow up a case by regular visits to half a year, 80 routine patients of healing all do not find the symptom of any recurrence.

1.3.2 matched group uses the pharmaceutical composition of comparative example 1 to treat at random:

(1) matched group: 100 routine patients use the compositions of comparative example 1, a 0.5 ~ 1g, 2 times on the one, continuous use is after 1 month, and drug withdrawal further consultation again in 1 week, adds up the routine patient treatment of discovery 32 effective, 21 routine patient treatments are effective, 47 routine patient treatments are invalid, follow up a case by regular visits to half a year, and statistics finds that 32 effective routine patients for the treatment of are recurred after wherein having 13 routine drug withdrawals.In addition, there is the symptom of diarrhoea or headache in patient when drug administration.Have take time there is headache, feel sick, the side effect such as diarrhoea.Have take time there is the side effect such as headache, flatulence.

2, conclusion: known by above-mentioned clinical trial: compared with matched group, the compositions of embodiment of the present invention 1-3 have healing time short, cure after the advantage that not easily recurs and have no side effect.

Model case

Model case 1:

Lee, man, 55 years old, goes to a doctor on May 1st, 2013.Patient has hypertension and coronary heart disease, more than 30 years of atrial fibrillation medical history, through common medicine.Occur over nearly 3 years that two lower limb are sent out cool, numb, movable rear pain.Concrete disease is seen: two lower limb pains, activity postemphasis, slightly light after rest, the colour of skin is purple dark, and two Calf muscle atrophys, have festering of diameter 5cm before left leg shin, wound surface depression is oozed out, and have palpitation, breathe hard, asthenia, dim complexion, light red tongue are dark, irregularly intermittent and regularly intermittent pulse, finger pressure nail matrix capillary filling time extends, survey ankle/upper arm index 0.6, T:37.9 DEG C, P:95 beat/min, R:25 beat/min, BP:165/95mmHg, blood glucose 5.4mmol/L, blood fat: triglyceride 2.5mmol/L, cholesterol 5.7mmol/L.Side's medicine: the daily tablet 2 times of the present embodiment 1, each serving with 0.5g, every day, half an hour took after meal, 1 week was a course for the treatment of, took 3 courses for the treatment of continuously, after treating 3 courses for the treatment of, patient two lower limb pain disappears, left leg rotten position heals, and Calf muscle is comparatively front plentiful, and the colour of skin gradually transfers to normally, have palpitation, alleviation of breathing hard, finger pressure nail matrix capillary filling time shortens, and survey ankle/upper arm index 0.9, blood pressure, blood fat, blood glucose all controlled within normal range.Advise and continue to take made tablet 2 months consolidate curative effect of the embodiment of the present invention 1 prescription, through repeatedly following up a case by regular visits to, so far without recurrence.

Model case 2:

Korea Spro, man, 61 years old, goes to a doctor on March 16th, 2013.Patient has hypertension history 13 years, occurs two lower limb pains after within 2 years, cause is suffered from cold, and once alleviates after locality treatment is taken medicine, then occur tired after two lower limb pains, slightly alleviate after rest, and pruritus cause two shank shins because of scratching before and inner side ulcer, merge in blocks.Once hirudiod external was used, heavy time light when festering, recurrent exerbation.Concrete symptom: atrophy that two lower limb muscles is slight, the colour of skin is purple dark, before shin and two medial legs fester, merge in flakes, skin ulcer face is oozed out, pain, activity postemphasis, during rest also bitterly, tucks and comforts foot, shallow complexion, lip is purple dark, and purplish tongue is dark, tongue is white, thready pulse without strength, finger pressure nail matrix capillary filling time extends, and surveys ankle/upper arm index

0.62, T:37.9 DEG C, P:88 beat/min, R:21 beat/min, BP:165/95mmHg, blood glucose 4.9mmol/L, blood fat: triglyceride 3.1mmol/L, cholesterol 6.4mmol/L.Side's medicine: the daily granule 2 times of the present embodiment 2, each serving with 0.5g, every day, half an hour took after meal, and 1 week was a course for the treatment of, took 3 courses for the treatment of continuously.After treating three courses for the treatment of, the two lower limb pain of patient disappears, and the colour of skin gradually recovers normal, form a scab with inner side rotten position before two shank shins, and the healing that comes off gradually, finger pressure nail matrix capillary filling time transfers to normally, surveying ankle/upper arm index is 1, and blood pressure, blood fat, blood glucose all controlled within normal range.Advise the preparation that continues to take the embodiment of the present invention 2 prescription 6 months, after drug withdrawal, through repeatedly following up a case by regular visits to, so far without recurrence.

Model case 3:

Flood certain, female, 68 years old, first visit on January 31 in 2013: patient's readme is dizzy, sleep poor, malaise, pain uncomfortable in chest, patient size is partially fat, red tongue with yellowish and greasy fur, stringy and rolling pulse, measuring blood pressure 203/98mmHg, looking into triglyceride is 4.61mmol/L, clinical diagnosis is atherosclerosis, method for the treatment of: the daily tablet 2 times of the compositions of the present embodiment 3, each serving with 1 ~ 2, every sheet 0.5g, every day, half an hour took after meal, and 1 week was a course for the treatment of, took 2-3 the course for the treatment of continuously, and advise it to keep on a diet, regulate life style.On March 5th, 2013 examines again: patient tells above-mentioned symptom and obviously disappears, and check triglyceride is 2.95mmol/L, measuring blood pressure 131/70mmHg.After taking 1 month again, patient tells above-mentioned symptom and disappears completely, and blood fat, blood pressure, all within normal range, are followed up a case by regular visits in 3 months and do not recurred.

Claims (9)

1. controlling an atherosclerotic pharmaceutical composition, it is characterized in that, is be made up of the raw material of following weight portion: fibrate 1 ~ 2 part, probucol 0.1 ~ 0.9 part, Chinese medicine composition 50 ~ 200 parts;

Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 8 ~ 20 parts, Rhizoma Curcumae 5 ~ 15 parts, Radix Puerariae 5 ~ 15 parts, 10 ~ 20 parts, Flos Sophorae, Pericarpium Citri Reticulatae 5 ~ 10 parts, Herba Hedyotidis Diffusae 15 ~ 20 parts, Semen Hoveniae (Fructus Hoveniae) 12 ~ 18 parts, Herba Epimedii 5 ~ 12 parts, the Rhizoma Atractylodis Macrocephalae 20 ~ 25 parts, Fructus Cnidii 5 ~ 10 parts, Radix Polygalae 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 5 ~ 8 parts, Rhizoma Polygoni Cuspidati 16 ~ 30 parts, Pollen Typhae 8 ~ 15 parts.

2. pharmaceutical composition as claimed in claim 1, it is characterized in that, be made up of the raw material of following weight portion: fibrate 1 ~ 1.2 part, probucol 0.1 ~ 0.3 part, Chinese medicine composition 100 ~ 180 parts;

Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 13 ~ 18 parts, Rhizoma Curcumae 8 ~ 12 parts, Radix Puerariae 12 ~ 15 parts, 10 ~ 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 ~ 10 parts, Herba Hedyotidis Diffusae 15 ~ 18 parts, Semen Hoveniae (Fructus Hoveniae) 14 ~ 18 parts, Herba Epimedii 8 ~ 12 parts, the Rhizoma Atractylodis Macrocephalae 22 ~ 25 parts, Fructus Cnidii 6 ~ 10 parts, Radix Polygalae 12 ~ 15 parts, Herb Gynostemmae Pentaphylli 6 ~ 8 parts, Rhizoma Polygoni Cuspidati 20 ~ 30 parts, Pollen Typhae 12 ~ 15 parts.

3. pharmaceutical composition as claimed in claim 2, it is characterized in that, be made up of the raw material of following weight portion: fibrate 1.2 parts, probucol 0.2 part, Chinese medicine composition 100 parts;

Described Chinese medicine composition is made up of the raw material of following weight portion, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Curcumae 10 parts, Radix Puerariae 12 parts, 15 parts, Flos Sophorae, Pericarpium Citri Reticulatae 8 parts, Herba Hedyotidis Diffusae 18 parts, Semen Hoveniae (Fructus Hoveniae) 15 parts, Herba Epimedii 10 parts, the Rhizoma Atractylodis Macrocephalae 22 parts, Fructus Cnidii 9 parts, Radix Polygalae 14 parts, Herb Gynostemmae Pentaphylli 8 parts, Rhizoma Polygoni Cuspidati 25 parts, Pollen Typhae 12 parts.

4. the pharmaceutical composition according to any one of claims 1 to 3, is characterized in that: fibrate is CLOF, bezafibrate, fenofibrate or its pharmaceutically acceptable salt or ester or derivatives thereof.

5. pharmaceutical composition as claimed in claim 4, is characterized in that: described fibrate is CLOF.

6. the pharmaceutical composition according to any one of claims 1 to 3, is characterized in that: the dosage form of described pharmaceutical composition is tablet, capsule, powder, granule or oral liquid.

7. the preparation method of the atherosclerotic pharmaceutical composition of the treatment according to any one of claim 1 ~ 6, is characterized in that, comprise the following steps:

(1) Chinese medicine ingredients is extracted: by the raw material of Chinese medicine except Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, add water until raw material of Chinese medicine described in submergence, decocts 1 ~ 2h, obtains decocting liquid, described decocting liquid is filtered, is removed slag, obtains filtrate; Concentrated described filtrate, obtains thick paste;

(2) sterilizing: described thick paste and described Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae are carried out sterilizing, 105-110 DEG C of sterilizing 20 ~ 30 minutes;

(3) dry: by the thick paste after sterilizing, Radix Puerariae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae and Pollen Typhae, at 60-80 DEG C of dry 6-7 hour;

(4) pulverize: dried raw material is added fibrate and probucol, is ground into 80-100 order fine powder, obtain medical treatment atherosclerotic pharmaceutical composition.

8. the pharmaceutical composition according to any one of claim 1 ~ 6 is in the application of preparation treatment atherosclerosis medicine.

9. apply as claimed in claim 8, it is characterized in that: described pharmaceutical composition coordinates other treatment atherosclerosis drug use.